Stevens Capital Management’s Novartis NVS Stock Holding History

Stevens Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,298	Closed	-$374K	–	208
2020 Q3	$374K	Buy	+4,298	New	+$372K	0.14%	87
2020 Q1	–	Sell	-2,122	Closed	-$201K	–	300
2019 Q4	$201K	Sell	2,122 -5,609	-73%	-$503K	0.02%	539
2019 Q3	$672K	Sell	7,731 -1,406	-15%	-$126K	0.06%	302
2019 Q2	$834K	Buy	+9,137	New	+$773K	0.04%	395
2018 Q4	–	Sell	-6,370	Closed	-$492K	–	844
2018 Q3	$492K	Sell	6,370 -13,854	-69%	-$1.02M	0.02%	531
2018 Q2	$1.37M	Buy	20,224 +4,272	+27%	+$295K	0.05%	384
2018 Q1	$1.16M	Sell	15,952 -1,210	-7%	-$92.1K	0.04%	384
2017 Q4	$1.29M	Buy	17,162 +11,401	+198%	+$860K	0.05%	377
2017 Q3	$443K	Buy	+5,761	New	+$435K	0.02%	579
2017 Q2	–	Sell	-12,898	Closed	-$858K	–	1000
2017 Q1	$858K	Buy	+12,898	New	+$859K	0.03%	452
2016 Q2	–	Sell	-15,775	Closed	-$1.02M	–	1062
2016 Q1	$1.02M	Sell	15,775 -7,418	-32%	-$505K	0.04%	423
2015 Q4	$1.79M	Buy	23,193 +13,772	+146%	+$1.09M	0.07%	310
2015 Q3	$776K	Sell	9,421 -40,351	-81%	-$3.59M	0.04%	411
2015 Q2	$4.39M	Sell	49,772 -8,398	-14%	-$770K	0.16%	178
2015 Q1	$5.14M	Buy	58,170 +27,384	+89%	+$2.43M	0.18%	144
2014 Q4	$2.56M	Sell	30,786 -12,365	-29%	-$1.02M	0.09%	256
2014 Q3	$3.64M	Sell	43,151 -16,295	-27%	-$1.32M	0.11%	233
2014 Q2	$4.82M	Buy	59,446 +51,382	+637%	+$4.04M	0.13%	207
2014 Q1	$614K	Sell	8,064 -23,661	-75%	-$1.72M	0.02%	607
2013 Q4	$2.29M	Buy	31,725 +6,941	+28%	+$482K	0.07%	312
2013 Q3	$1.7M	Sell	24,784 -22,261	-47%	-$1.47M	0.05%	369
2013 Q2	$2.98M	Buy	+47,045	New	+$3.06M	0.1%	242

Other funds holding NVS

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Stevens Capital Management's NVS Position: Q4 2020 in Review

Stevens Capital Management sold out of Novartis (NVS) in Q4 2020, closing a stake of 4,298 shares — an estimated $374K sold.

Stevens Capital Management first reported a position in NVS in Q2 2013 and held it in 22 quarters. The position peaked at $5.14M in Q1 2015. 1,177 funds tracked by Wall St. Rank hold NVS as of Q4 2020.

Stevens Capital Management reported no remaining Novartis position as of Q4 2020 after selling out during the quarter.
Stevens Capital Management sold 4,298 Novartis shares in Q4 2020, an estimated $374K.
Stevens Capital Management first reported a position in Novartis in Q2 2013 and held it in 22 quarters.
Stevens Capital Management's Novartis position peaked at $5.14M in Q1 2015.
1,177 funds tracked by Wall St. Rank held Novartis as of Q4 2020.

Based on Stevens Capital Management's 13F filing for Q4 2020, filed 8 Feb 2021.